ORKA (STOCKS)
Oruka Therapeutics, Inc. Common Stock
$62.000000
+2.420000 (+4.06%)
Prev close: $59.580000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Lawrence O. Klein
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,038.95M
- Employees
- 28
- P/E (TTM)
- -26.48
- P/B (TTM)
- 6.19
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $16.62M |
| Operating Expenses | $122.05M |
| Research and Development | $100.64M |
| Other Operating Expenses | $21.41M |
| Operating Income/Loss | -$122.05M |
| Income/Loss From Continuing Operations After Tax | -$105.43M |
| Income/Loss From Continuing Operations Before Tax | -$105.43M |
| Net Income/Loss | -$105.43M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$105.43M |
| Net Income/Loss Available To Common Stockholders, Basic | -$105.43M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Assets | $488.62M |
| Current Assets | $343.86M |
| Noncurrent Assets | $144.76M |
| Fixed Assets | $288.00K |
| Other Non-current Assets | $144.47M |
| Liabilities | $16.69M |
| Current Liabilities | $15.37M |
| Noncurrent Liabilities | $1.31M |
| Equity | $471.93M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $471.93M |
| Liabilities And Equity | $488.62M |
| Net Cash Flow From Operating Activities | -$88.21M |
| Net Cash Flow From Operating Activities, Continuing | -$88.21M |
| Net Cash Flow From Investing Activities | -$96.75M |
| Net Cash Flow From Investing Activities, Continuing | -$96.75M |
| Net Cash Flow From Financing Activities | $170.32M |
| Net Cash Flow From Financing Activities, Continuing | $170.32M |
| Net Cash Flow | -$14.64M |
| Net Cash Flow, Continuing | -$14.64M |
| Comprehensive Income/Loss | -$104.85M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$104.85M |
| Other Comprehensive Income/Loss | -$104.85M |